Magnus Medical
Burlingame, US · Founded 2020 · Delaware corporation · 2 known investors
Developing closed-loop neuromodulation technology to treat intractable neurological and psychiatric disorders.
Biotech
Founders & leadership
CG
Christian GormsenExecutive Officer, Director
VL
Vikram LambaExecutive Officer
XC
Xingjuan ChaoDirector
NW
Nolan WilliamsDirector
HL
Heath LukatchDirector
AF
Andrew FirlikDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$49MraisedMay 2026 · 10 investors · BiotechnologyRule 506(b)
▶$49MraisedMay 2026 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Heath LukatchDirector
- Andrew FirlikDirector
- Achal AchrolExecutive Officer, Director
- Brandon BentzleyExecutive Officer, Director
- Offering amount
- $77M
- Amount sold
- $49M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.3MraisedMar 2025 · 10 investors · BiotechnologyRule 506(b)
▶$40.3MraisedMar 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christian GormsenExecutive Officer, Director
- Vikram LambaExecutive Officer
- Xingjuan ChaoDirector
- Nolan WilliamsDirector
- Andrew FirlikDirector
- Heath LukatchDirector
- Offering amount
- $59M
- Amount sold
- $40.3M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.